Skip to main content

Table 2 Serial measurements

From: Long-term comprehensive cardiopulmonary phenotyping of COVID-19

 

 < 6 weeks

3 months

6 months

12 months

Mean

SD

n

Mean

SD

n

Mean

SD

n

Mean

SD

n

PFTs

FEV1

54.59

12.505

6

89.66

17.732

45

92.27

18.418

51

95.005

12.029

21

FVC

46.044

13.617

6

83.965

21.607

44

88.94

16.105

51

91.684

14.995

22

FEV1/VC

91.482

6.71

6

81.453

10.33

45

78.893

10.649

51

77.529

6.107

21

RV

86.774

44.355

6

93.254

28.799

44

100.31

33.121

51

93.044

14.318

22

TLC

59.863

19.64

6

89.027

20.146

44

96.447

15.467

51

94.796

11.811

22

DLCO

47.5

7.778

2

62.413

18.587

41

70.044

13.088

46

68.041

13.69

22

SaO2

97

1.583

6

96.616

1.643

43

96.864

1.302

50

96.914

1.44

21

paO2

85.38

31.559

6

78.591

10.515

44

81.212

9.728

49

80.66

9.751

21

Echocardiography

LVEF

57

1.826

4

57.909

3.961

11

58.067

4.712

30

56

n.A

1

LVEF by EPSS

66.85

6.095

5

63.363

4.973

31

64.743

5.47

38

65.484

6.443

16

Longitudinal Strain

− 24.025

4.246

4

− 21.354

2.738

13

− 23.139

4.349

28

− 18

NA

1

TAPSE

21.87

5.503

10

21.938

3.282

34

22.649

3.329

47

22.221

2.531

19

TAPSE/sPAP

0.692

0.359

6

0.781

0.185

22

0.875

0.297

24

0.843

0.154

9